Rup Tandan

7.4k total citations
81 papers, 3.0k citations indexed

About

Rup Tandan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Rup Tandan has authored 81 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Neurology, 17 papers in Cellular and Molecular Neuroscience and 16 papers in Molecular Biology. Recurrent topics in Rup Tandan's work include Amyotrophic Lateral Sclerosis Research (24 papers), Peripheral Neuropathies and Disorders (18 papers) and Hereditary Neurological Disorders (13 papers). Rup Tandan is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (24 papers), Peripheral Neuropathies and Disorders (18 papers) and Hereditary Neurological Disorders (13 papers). Rup Tandan collaborates with scholars based in United States, United Kingdom and Italy. Rup Tandan's co-authors include Walter G. Bradley, Timothy J. Fries, Waqar Waheed, Diantha B. Howard, Michael K. Hehir, Hiroshi Mitsumoto, Mark B. Bromberg, Richard J. Barohn, Tahseen Mozaffar and William W. Pendlebury and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Neurology.

In The Last Decade

Rup Tandan

78 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rup Tandan United States 25 2.0k 735 696 541 490 81 3.0k
Yadollah Harati United States 32 2.1k 1.0× 577 0.8× 856 1.2× 926 1.7× 915 1.9× 71 3.8k
Pierre‐François Pradat France 30 2.6k 1.3× 1.5k 2.1× 425 0.6× 669 1.2× 364 0.7× 77 3.4k
Ken Ikeda Japan 24 1.3k 0.6× 458 0.6× 782 1.1× 816 1.5× 303 0.6× 167 3.0k
Michael A. van Es Netherlands 30 2.7k 1.4× 1.5k 2.0× 443 0.6× 1.0k 1.9× 468 1.0× 83 3.6k
Takashi Kasai Japan 26 1.1k 0.5× 184 0.3× 334 0.5× 720 1.3× 908 1.9× 73 2.5k
Stephan Zierz Germany 34 847 0.4× 364 0.5× 557 0.8× 2.0k 3.7× 533 1.1× 175 3.6k
Stacey A. Sakowski United States 28 819 0.4× 603 0.8× 541 0.8× 959 1.8× 508 1.0× 50 2.3k
Kuen‐Jer Tsai Taiwan 28 936 0.5× 347 0.5× 360 0.5× 1.1k 2.0× 744 1.5× 77 2.9k
Yasuhiro Manabe Japan 26 694 0.3× 268 0.4× 523 0.8× 610 1.1× 195 0.4× 152 2.3k
Masaki Takao Japan 28 998 0.5× 147 0.2× 396 0.6× 1.4k 2.5× 600 1.2× 160 3.1k

Countries citing papers authored by Rup Tandan

Since Specialization
Citations

This map shows the geographic impact of Rup Tandan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rup Tandan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rup Tandan more than expected).

Fields of papers citing papers by Rup Tandan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rup Tandan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rup Tandan. The network helps show where Rup Tandan may publish in the future.

Co-authorship network of co-authors of Rup Tandan

This figure shows the co-authorship network connecting the top 25 collaborators of Rup Tandan. A scholar is included among the top collaborators of Rup Tandan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rup Tandan. Rup Tandan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tandan, Rup, et al.. (2022). Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival. American Journal of Clinical Nutrition. 115(5). 1378–1392. 13 indexed citations
2.
Stommel, Elijah W., Kristen Riley, Rup Tandan, et al.. (2017). Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS). Journal of Neurology. 264(8). 1763–1767. 4 indexed citations
3.
Andrew, Angeline S., Tracie A. Caller, Rup Tandan, et al.. (2017). Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New England. Neurodegenerative Diseases. 17(2-3). 110–116. 52 indexed citations
4.
Stommel, Elijah W., Celia Y. Chen, Tracie A. Caller, et al.. (2017). Fish consumption, mercury levels, and amyotrophic lateral sclerosis (ALS) (S15.008). Neurology. 88(16_supplement). 1 indexed citations
5.
Kasarskis, Edward J., Marta S. Mendiondo, Dwight E. Matthews, et al.. (2014). Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. American Journal of Clinical Nutrition. 99(4). 792–803. 65 indexed citations
6.
Wills, Anne‐Marie, Jane Hubbard, Eric A. Macklin, et al.. (2014). Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. The Lancet. 383(9934). 2065–2072. 198 indexed citations
7.
Benatar, Michael & Rup Tandan. (2011). Reply. Muscle & Nerve. 44(3). 457–457. 1 indexed citations
8.
Tandan, Rup, et al.. (2011). Aortic dissection presenting as pleural effusion. BMJ Case Reports. 2011. bcr0320113956–bcr0320113956. 3 indexed citations
9.
Tandan, Rup, et al.. (2008). Safety of Liquid Intravenous Immunoglobulin for Neuroimmunologic Disorders in the Home Setting: A Retrospective Analysis of 1085 Infusions. Journal of Clinical Neuromuscular Disease. 10(2). 52–55. 12 indexed citations
10.
Haq, Rizwan ul, William W. Pendlebury, Timothy J. Fries, & Rup Tandan. (2003). Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle & Nerve. 27(4). 465–470. 46 indexed citations
11.
Collet, Jean‐Paul, Michaël Pollak, Stan Shapiro, et al.. (2001). Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome. Journal of the Neurological Sciences. 182(2). 107–115. 18 indexed citations
12.
Bromberg, Mark B., Timothy J. Fries, Dallas Forshew, & Rup Tandan. (2001). Electrophysiologic endpoint measures in a multicenter ALS drug trial. Journal of the Neurological Sciences. 184(1). 51–55. 15 indexed citations
13.
Mendell, Jerry R., Richard J. Barohn, Miriam Freimer, et al.. (2001). Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 56(4). 445–449. 243 indexed citations
14.
Tandan, Rup, Mark B. Bromberg, Dallas Forshew, et al.. (1996). A controlled trial of amino acid therapy in amyotrophic lateral sclerosis. Neurology. 47(5). 1220–1226. 56 indexed citations
15.
Robison, Steven H., Rup Tandan, & Walter G. Bradley. (1993). Repair of N-methylpurines in DNA from lymphocytes of patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 115(2). 201–207. 3 indexed citations
16.
Tandan, Rup, et al.. (1992). Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up. Diabetes Care. 15(1). 8–14. 141 indexed citations
17.
Tandan, Rup, Walter G. Bradley, & Michael Fillyaw. (1990). Giant axonal neuropathy: studies with sulfhydryl donor compounds. Journal of the Neurological Sciences. 95(2). 153–162. 4 indexed citations
18.
Fillyaw, Michael, Gary J. Badger, Walter G. Bradley, et al.. (1989). Quantitative measures of neurological function in chronic neuromuscular diseases and ataxia. Journal of the Neurological Sciences. 92(1). 17–36. 20 indexed citations
19.
Tandan, Rup & Timothy J. Fries. (1988). Continuous motor unit activity confined to the upper extremities. Muscle & Nerve. 11(3). 255–260. 6 indexed citations
20.
Tandan, Rup & Walter G. Bradley. (1985). Amyotrophic leteral sclerosis: Part 2. Etiopathogenesis. Annals of Neurology. 18(4). 419–431. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026